Literature DB >> 7002425

Effects of pindolol on renal function.

E Wainer, G Boner, J B Rosenfeld.   

Abstract

Because beta blockers have been shown to reduce glomerular filtration rate (GFR), the renal effect of intravenous and prolonged oral administration of pindolol was examined in 10 patients with essential hypertension. Intravenous pindolol decreased inulin clearance from 99 to 94 ml/min/1.73 m2 (p < 0.005), and pulse rate from 75 to 69/min (p < 0.005). Blood pressure and filtration fraction were not changed. Oral pindolol (10 to 20 mg/day) for a mean of 6 mo resulted in a decrease in mean blood pressure from 124 to 111 mm Hg (p < 0.001), in mean pulse rate from 76 to 69/min (p < 0.005), and in mean plasma renin activity (PRA) from 0.9 to 0.29 ng/ml/hr (p < 0.05). Inulin clearance and filtration fraction did not change. At the end of oral therapy, intravenous pindolol induced a greater reduction in inulin clearance than in the first study. These observations indicate that intravenous pindolol induces a decrease in GFR probably secondary to hemodynamic effects. On the other hand, prolonged oral pindolol has no effect on GFR despite decreases in blood pressure, pulse rate, and PRA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7002425     DOI: 10.1038/clpt.1980.205

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  9 in total

1.  Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.

Authors:  T Baba; S Murabayashi; K Aoyagi; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 2.  Beta-blockers and renal function.

Authors:  R Wilkinson
Journal:  Drugs       Date:  1982-03       Impact factor: 9.546

3.  Renal function during acute and long term pindolol treatment in hypertensive patients with normal and decreased glomerular filtration.

Authors:  J Rosenfeld; G Boner; E Wainer
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

4.  Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol.

Authors:  A S Gross; A J McLachlan; I Minns; J B Beal; S E Tett
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

5.  Comparison of the renal effects of dilevalol and carteolol in patients with mild to moderate essential hypertension.

Authors:  T Baba; S Murabayashi; T Tomiyama; K Takebe
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Responses of glomerular filtration, renal blood flow and salt-water handling to acute cardioselective and non-selective beta-adrenoceptor blockade in essential hypertension.

Authors:  G Koch; L Fransson; L Karlegärd; P Kothari
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 7.  Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.

Authors:  W H Aellig
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

8.  Determining the mechanisms underlying augmented renal drug clearance in the critically ill: use of exogenous marker compounds.

Authors:  Andrew A Udy; Paul Jarrett; Janine Stuart; Melissa Lassig-Smith; Therese Starr; Rachel Dunlop; Steven C Wallis; Jason A Roberts; Jeffrey Lipman
Journal:  Crit Care       Date:  2014-11-29       Impact factor: 9.097

9.  Conventional Pig as Animal Model for Human Renal Drug Excretion Processes: Unravelling the Porcine Renal Function by Use of a Cocktail of Exogenous Markers.

Authors:  Laura Dhondt; Siska Croubels; Peter De Paepe; Steven C Wallis; Saurabh Pandey; Jason A Roberts; Jeffrey Lipman; Pieter De Cock; Mathias Devreese
Journal:  Front Pharmacol       Date:  2020-06-12       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.